IndraLab

Statements

Lapatinib inhibits NFKB1. 1 / 1

| 1

reach

"54 Lapatinib on the other hand does not inhibit NFkB activation which may further contribute to its relative cardiac sparing effect.Although the target is the same, clinical results with lapatinib ind[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

19640652

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Lapatinib inhibits NFKB1. 1 / 1

INDRA sources:

Databases

Reading